Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose oral minoxidil is a safe treatment for hair loss, with the main side effect being excessive hair growth. Other side effects like foot swelling, low blood pressure when standing, and heart rate changes are rare.

The document concludes that topical minoxidil therapy is safe and effective in promoting hair growth for male pattern baldness.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Telogen effluvium is a reversible hair loss condition that requires a detailed diagnosis and often resolves on its own.

Women look young for their age due to larger lips, less sun damage, and genes that prevent gray hair and wrinkles.

Oral finasteride works better than topical minoxidil for hair growth, both are safe.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

Hair loss treatments work better with lifestyle changes.

Low-level laser therapy effectively treats female hair loss, increasing hair count by 51%.

Low-level light therapy safely improves hair coverage, thickness, and count in androgenetic alopecia patients.

PTH-CBD could help prevent and treat hair loss caused by chemotherapy in mice.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

Biotin supplements are unnecessary for most people but may help with certain conditions like biotin deficiency, brittle nails, and some hair loss.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

The document concludes that treatments for female hair loss and excess body hair are available, but managing expectations is important.

Janus kinase inhibitors are effective and generally safe for treating hair loss in adults with alopecia areata.

Premature graying and hair changes can be treated with certain peptides and possibly targeting the endocannabinoid system.

The paper concludes that understanding melanocyte development can help in insights into skin diseases and melanoma diversity.

Minoxidil and Finasteride are effective for male baldness; more research is needed for hair aging treatments.

Future hair cosmetics will be safer and more effective.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Plant extracts may help prevent or reverse hair graying.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

About 12% of children in Kota, Rajasthan, experience hair loss, mainly due to fungal infections, with early treatment advised to prevent worsening.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Some treatments for hereditary hair loss are effective but vary in results and side effects; new therapies show promise but need more research.